Viewing Study NCT03296033

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:03 AM
Ignite Modification Date: 2026-01-07 @ 12:12 PM
Study NCT ID: NCT03296033
Status: TERMINATED
Last Update Posted: 2023-10-05
First Post: 2017-07-06
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Residual Anti-Xa Activity After Last Treatment Dose of Enoxaparin
Sponsor: Wake Forest University Health Sciences
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Anticoagulants and Bleeding Disorders View
None Surgery View
None Regional Anesthesia Morbidity View
Keywords:

Keywords

Keyword Brief Keyword Text View
None enoxaparin View
None thromboembolism View
None coagulation View
None factor Xa View